本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

13.39
-0.1500-1.11%
盤後13.390.00000.00%16:23 EDT
成交量:28.48萬
成交額:382.52萬
市值:14.09億
市盈率:-8.64
高:13.79
開:13.52
低:13.34
收:13.54
資料載入中...
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/26

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report